Your medical cannabis journey simplified: find partnered dispensaries, explore pricing options, earn rewards, and get answers to FAQs, all in one spot.
Colorado is boldly moving to bring cannabis sales online, Florida’s attorney general put a damper on the state’s legalization push, and a Massachusetts biotech company began developing a psilocybin-based drug.
Let’s dive into this week’s canna-news.
Colorado’s Online Cannabis Revolution
Colorado is bringing its wildly popular cannabis industry online! Last week, Colorado Gov. Jared Polis signed a bill to legalize online sales of cannabis.
Online sales are restricted to individuals 21 and up and must be picked up in person. At pick-up, retailers are required to verify the identification and age of the purchaser match up with the person picking up. Retailers must also provide digital versions of all their warnings and educational content for shoppers to read through before purchasing.
Colorado lawmakers hope the new law will help reduce the cannabis industry’s reliance on cash transactions. In Colorado and other legal states, cash surpluses in dispensaries have made them prime targets for robbery.
What do you think about Colorado bringing their cannabis industry online? Would you like to see something like this in your own state? Let us know in the comments!
See If You Qualify For Medical Marijuana -Select Your State!
Florida Sets Stage for 2024 Cannabis Face-off
A cannabis legalization initiative backed by cannabis company Trulieve is making its way to Florida’s 2024 ballot! Late last month, Florida’s Division of Elections confirmed that 967,528 signatures had been gathered in support of the initiative. The number surpassed the 891,523 signatures needed to put it on the ballot. Unfortunately, the initiative still has several hurdles to jump through before it can get to the ballots.
To start, Florida’s Attorney General Ashely Moody has initiated a legal challenge against the proposed measure. Moody argues that the initiative violates the state constitution’s “single subject” rule for ballot measures. This same rule was used by the Supreme Court to invalidate a legalization measure proposed in 2022.
If the legalization is able to make it to the ballot, however, this is what voters can expect. The measure would allow medical cannabis businesses to sell cannabis to all adults over 21. Adults would be allowed to purchase and possess up to 3 ounces of cannabis or 5 grams of concentrate for personal use.
Other than that, the proposed initiative is relatively bare bones. It includes no provisions for home cultivation, expungement of records, or any social equity measures. While this may seem odd, it should help the measure avoid breaking the “single subject” law that doomed its predecessor.
Massachusetts-based biotech company Enteric Biosciences is looking to become a leader in psilocybin medicine. The company recently received a patent for its psilocybin-based drug currently under development.
The company is partnering with Avance Clinical out of Australia to conduct its studies. Enteric Biosciences hopes the drug will provide folks with anxiety, depression, and addiction disorders a more effective treatment option.
Mexico-born and California-raised, Cesar is a Marketing Associate at Veriheal. When he’s not scouring social media for the latest internet drama, you can find him working on yet another collage project.
There is no way Florida will legalize marijuana anytime soon. Whether or not an overwhelming majority supports it or not is irrelevant. The only person’s opinion that matters in that god-forsaken state is that of Ron Desatan, the bobble-headed governor. He will use any and all methods of repression on Floridians to assure things are just the way HE wants them.
Mental health is crucial to our well-being. The National Institute of Mental Health (NIMH) estimates that more than one in five U.S. adults is currently living with a mental health condition. The effort to destigmatize the conversations around mental health is recognized from Mental Health Awareness Month in May to World Suicide Prevention Day in…
For years, celebrities looking for their next investment opportunity or endorsement deal have flocked to the alcohol industry. With its huge market value ($2,313.2 billion in 2023), expected growth (Fortune Business Insights predicts it will top $5,716.2 billion by 2032), and abundance of brands eager to differentiate themselves from a sea of similar products, the…
Anecdotal and scientific evidence highlighting cannabis medical and therapeutic benefits is plentiful, boosting the plant’s reputation as a wonder herb. Some even consider the marijuana plant the closest we may ever get to a fountain of youth. But is that true? Can cannabis really help you live longer or reverse the effects of aging? Willie…
Cannabis is (nearly) as old as time. Fossil records have determined that the plant sprang up sometime in the middle of the Oligocene epoch, 34-23 million years ago, on the Tibetan Plateau, a region that is now home to Kazakhstan and Kyrgyzstan. One or more Neolithic groups likely domesticated it, and it traveled throughout Asia…
On June 5, 1981, the US Centers for Disease Control published an article titled “Pneumocystis Pneumonia– Los Angeles” that reported on five cases of a rare lung infection in previously healthy, young, gay men in Los Angeles. The story revealed that along with this rare lung condition, the men had other uncommon infections, implying that…
The statements made regarding cannabis products on this website have not been evaluated by the Food and Drug Administration (FDA). Cannabis is not an FDA-approved substance and is still illegal under federal law. The information provided on this website is intended for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. It is not intended as medical advice and should not be considered as a substitute for advice from a healthcare professional. We strongly recommend that you consult with a physician or other qualified healthcare provider before using any cannabis products. The use of any information provided on this website is solely at your own risk.